Results 81 to 90 of about 19,721 (235)

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Chronic pruritus (CP) and chronic prurigo (CPG, including prurigo nodularis) are prevalent, debilitating diseases with diverse comorbidities, including malignancies. This retrospective cohort study evaluated the prevalence and risk of lymphoma in CP and CPG patients, including key risk factors, and sex‐ and ancestry ...
Svenja Royeck, Henning Olbrich, Steffen Koschmieder, Claudia Zeidler, Felix Witte, Konstantin Agelopoulos, Henning Wiegmann, Michael Storck, Johannes Benedict Oehm, Ralf J. Ludwig, Sonja Ständer   +10 more
wiley   +1 more source

Paraneoplastic neurological syndromes

Ceylon Medical Journal, 2009
Almost any part of the nervous system can be affected by paraneoplastic syndromes. It is important to recognise paraneoplastic neurological syndromes (PNS), for several reasons. They usually predate symptoms of the malignancy, and identification should lead to a search for the primary tumour.
openaire   +3 more sources

Paraneoplastic Syndromes of the Central Nervous System [PDF]

, 1996
In recent years a continuous stream of new information on clinical, pathological and immunological aspects of paraneoplastic neurological syndromes has been published.
Moll, J.W.B. (Wibe)
core   +1 more source

Autonomic paraneoplastic neurological syndromes

, 2007
Autonomic paraneoplastic neurological syndromes (PNS) typically present as chronic gastrointestinal pseudo-obstruction or orthostatic hypotension and usually occur in association with other PNS rather than in isolation.
HART IK, RICEVUTI, GIOVANNI, FERRARI D, LORUSSO L, NGONGA GK, GASPARETTO C   +5 more
core   +1 more source

Successful Treatment in a Case of Massive Hepatocellular Carcinoma with Paraneoplastic Syndrome

Case Reports in Gastroenterology, 2009
Paraneoplastic syndromes of hepatocellular carcinoma (HCC) are not uncommon. However, the prognosis is poor and follow-up and improvement of paraneoplastic syndromes with treatment have been reported rarely.
Atsunori Tsuchiya, Tomoyuki Kubota, Kazuyoshi Takizawa, Kazuki Yamada, Toshifumi Wakai, Yasunobu Matsuda, Terasu Honma, Masashi Watanabe, Yoshio Shirai, Hiroki Maruyama, Minoru Nomoto, Yutaka Aoyagi   +11 more
doaj   +1 more source

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

Internal Medicine Journal, EarlyView.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar, Jun Yen Ng, Adam Bryant, Annmarie Bosco, Hugh C. Caterson, Pratyush Giri, Pravin Hissaria, Simon J. Harrison, Stephen Lade, Connull Leslie, Jacinta Perram, H. Miles Prince, Dejan Radeski, Maureen Rischmueller, Craig Wallington‐Gates, Nicholas Weber, Alberta Hoi   +16 more
wiley   +1 more source

Paraneoplastic Neurological Syndromes: Clinical And Serological Studies [PDF]

, 2011
The term “paraneoplastic syndromes” refers to symptoms or signs resulting from damage to organs or tissues that are remote from the site of a malignant neoplasm or its metastases.
Shamsili, S.G. (Setareh), Shams'ili, S
core  

Paraneoplastic Neuromuscular Disorders : Evidence - Based Screening Approach For Systemic Cancers

Annals of Indian Academy of Neurology, 1998
Paraneoplastic neuromuscular disorders though rare are an important group of conditions. Prompt recognition of these syndromes should lead to a careful search for an otherwise occult and often treatable cancer.
Mathuranath P.S, Sarada C, Radhakrishnan K   +2 more
doaj  

Clinical challenges of paraneoplastic endocrine metabolic syndromes: An illustrative example

Journal of Clinical and Translational Endocrinology Case Reports
Background/objective: Paraneoplastic endocrine metabolic syndromes are rare, but clinically significant manifestations of underlying malignancies, often complicating clinical course and impacting treatment outcomes.
Srushti Shankar, Sumal S. Sundar, Madhumati S. Vaishnav, Leena Lekkala, Chandraprabha Siddalingappa, Kavitha Muniraj, Thummala Kamala, Reshma B. Vijay, Vasanthi Nath, Mandyam D. Chitra, Pushpa Ravikumar, Siddartha Dinesha, Tejeswini Deepak, Srikanta Sathyanarayana   +13 more
doaj   +1 more source

The m.14484T>C MT‐ND6 Mutation Presenting with a Hereditary Spastic‐Paraparesis Phenotype

Movement Disorders Clinical Practice, EarlyView.
Gabriel Amorelli, Christelle Nilles, Gerald Pfeffer, Matthew Joel, Davide Martino   +4 more
wiley   +1 more source